In Vitvo Induction of Differentiation by Ginsenoside Rh2 in SMMC-7721 Hepatocarcinoma Cell Line

Pharmacology and Toxicology

Volumn 93, Issue 6, 2003, Pages 275-283

  Zeng, Xiao Li ^a   Tu, Zhi Guang ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN E; GAMMA GLUTAMYLTRANSFERASE; GINSENOSIDE; GINSENOSIDE RH 2; MESSENGER RNA; PROTEIN P16; PROTEIN P21; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL FUNCTION; CELL METABOLISM; CELL PROLIFERATION; CELL STRUCTURE; CELL ULTRASTRUCTURE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SPECIFICITY; INHIBITION KINETICS; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REDUCTION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; CYTOLOGY; ENZYMOLOGY; HUMAN; METABOLISM; SECRETION; TUMOR CELL LINE;

ALPHA-FETOPROTEINS; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; GAMMA-GLUTAMYLTRANSFERASE; GINSENOSIDES; HUMANS; TELOMERASE;

EID: 0346041545     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.2003.pto930605.x     Document Type: Article

References (35)

1. Alley, M. C., M. L. Hursey, R. H. Shoemarker, J. G. Mayo, A. Monks, D. A. Scudiero, M. R. Boyd, M. J. Czerwinski, D. L. Fine & B. J. Abbott: Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 1988, 48, 589-601.
2. Asmah, R., M. Azhar & W. N. W. Zurinah: Effects of dexamethasone and tocotrienol on alkaline phosphatase in rats with induced hepatocarcino-genesis. Proc. Malays. Biochem. Soc. Conf. 19th, 1994, 181-184.
3. Baek, N. I., D. S. Kim, Y. H. Lee, J. D. Park, C. B. Lee & S. I. Kim: Cytotoxicities of ginseng saponins and their degradation products against some cancer cell lines. Arch. Pharm. Res. 1995, 18, 164-168.
4. Beattie, T. L., W. Zhou, M. O. Robinson & L. Harrington: Reconstitution of human telomerase activity in vitro. Curr. Biol. 1998, 8, 177-180.
5. Chen, J., P. K. Jackson, M. W. Kirschner & A. Dutta: Separate domains of p21 involved in the inhibition of cdk kinase and PCNA. Nature 1995, 374, 386-388.
6. Cheng, A. J., S. K. Liao, S. E. Chow, J. K. Chen & T. C. Wang: Differentialinhibition of telomerase activity during induction of differentiation in hematopoietic, melanoma and glioma cells in culture. Biochem. Biophys. Res. Commun. 1997, 237, 438-444.
7. Counter, C. M., M. Meyerson, E. N. Eaton, L. W. Ellisen, S. D. Caddle, D. A. Haber & R. A. Weinberg: Telomerase activity restored in human cells by ectopic expression of hTERT (HEST2), the catalytic subunits of telomerase. Oncogene 1998, 16, 1217-1222.
8. Grana, X. & E. P. Reddy: Cell cycle control in mammalian cells: role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene 1995, 11, 211-219.
9. Greider, C. W. & E. H. Blackburn: A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis. Nature 1989, 337, 331-337.
10. Hisatake, J., Y. Kubota, M. Uskokovic, S. Tomoyasu & H. P. Koeffler: 5,6-trans-16-ene-vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells. Cancer Res. 1999, 59, 4023-4029.
11. 4 concentration in cultured rat heptocytes. Biochem. Toxicol. 1995, 10, 239-243.
12. Huang, W. C. & L. Y. Chuang: Sodium butyrate enhances STAT1 expression in PLC/PRF/5 hepatoma cells and augments their responsiveness to interferon-alpha. Brit. J. Cancer 1999, 80, 705-710.
13. Jensen, S. S., M. W. Madsen, J. Lukas, L. Binderup & J. Bartek: Inhibitory effects of 1alpha, 25-dihydroxyvitamin D3 on the G1-S phase-controlling machinery. Mol. Endocrinol. 2001, 15, 1370-1380.
14. 2-phase of the cell cycle by 9-nitrocamptothecin. Lab. Invest. 1995, 73, 118-127.
15. 2. Int. J. Biochem. Cell Biol. 1998, 30, 327-338.
16. 6 glioma via a reactive oxygen-and caspase-dependent but Bcl-X (L)-independent pathway. Life Sci. 1999, 65, PL33-40.
17. Kim, Y. H., K. H. Park & H. M. Rho: Transcriptional activation of the Cu, Zn-superoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medical plant, Panax ginseng. J. Biol. Chem. 1996, 271, 24539-24543.
18. Kim, N. W., M. A. Piatyszek, K. R. Prowse, C. B. Harley, M. D. West, P. L. C. Ho, G. M. Coviello, W. E. Wright, S. L. Weinrich & J. W. Shay: Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC) 1994, 266, 2011-2015.
19. Lee, Y. N., H. Y. Lee, H. Y. Chung, S. I. Kim, S. K. Lee, B. C. Park & K. W. Kim: In vitro induction of differentiation by ginsenoside in F9 teratocarcinoma cells. Eur. J. Cancer 1996, 32A, 1420-1428.
20. Lin, Z., S. Lim, M. A. Viani, M. Sapp & M. S. Lim: Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents. Amer. J. Pathol. 2001, 159, 711-719.
21. Lu, Y., Q. Lu & H. L. Chen: Diagnosis of primary liver cancer using lectin affinity chromatography of serum alkaline phosphatase. J. Exp. Clin. Cancer Res. 1997, 16, 75-80.
22. Mano, Y., T. Shimizu, S. Tanuma & K. Takeda: Synergistic down-regulation of telomerase activity and hTERT mRNA expression by combination of retinoic acid and GM-CSF in human myeloblastic leukemia ML-1 cells. Anticancer Res. 2000, 20, 1649-1652.
23. Miyazawa, K., M. Yaguchi, K. Funato, A. Gotoh, Y. Kawanishi, Y. Nishizawa, A. Yuo & K. Ohyashiki: Apoptosis/differentiation-inducing effects of vitamin K2 on HL-60 cells, dichotomous nature of vitamin K2 in leukemia cells. Leukemia 2001, 15, 1111-1117.
24. Nakamura, M., H. Saito, H. Ebinuma, K. Wakabayashi, Y. Saito, T. Takagi, N. Nakamoto & H. Ishii: Reduction of telomerase activity in human liver cancer cells by a histone deacelylase inhibitor. J. Cell. Physiol. 2001, 187, 392-401.
25. 2 on tumor growth in nude mice bearing human ovarian cells. Jap. J. Cancer 1998, 89, 733-740.
26. 2-induced apoptosis. Cancer Letters 1997, 121, 73-81.
27. Pendino, F., M. Flexor, F. Delhommeau, D. Buet, M. Lanotte & E. Segal-Bendirdjian: Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proc. Natl. Acad. Sci. USA 2001, 98, 6662-6667.
28. Saito, H., H. Ebinuma, M. Takahashi, F. Kaneko, K. Wakabayashi, M. Nakamura & H. Ishii: Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression. Hepatology 1998, 27, 1233-1240.
29. Saito, Y., H. Hatta, Y. Mano, N. Taira, T. Shimizu & K. Takeda: Vitamin D3 analogue KH1060 combined with TPA synergistically induces mature macrophages in human myeloblastic leukemia ML-1 cells. Anticancer Res. 1999, 19, 1069-1076.
30. Sharma, H. W., J. A. Sokoloski, J. R. Perez, J. Y. Maltese, A. C. Sartorelli, C. A. Stein, G. Nichols, Z. Khaled, N. T. Telang & R. Narayanan: Differentiation of immortal cells inhibits telomerase activity. Proc. Natl. Acad. Sci. USA 1995, 92, 12343-12346.
31. 1 cyclin-dependent kinases. Genes Dev. 1995, 9, 1149-1163.
32. 1 arrest during neuronal differentiation of human prostatic cancer TSU-Pr1 cells by staurosporine. Anticancer Res. 2001, 21, 893-898.
33. Sporn, M. B. & A. B. Roberts: Role of retinoids in differentiation and carcinogenesis. Cancer Res. 1983, 43, 3034-3040.
34. Tode, T., Y. Kikuchi, J. Hirata, T. Kita & I. Nagata: Effects of red ginseng on the neuroimmunoendocrine functions in patients after surgery of ovarian carcinoma or with perimenopausal complaints. Ginseng Rev. 1996, 22, 110-114.
35. 2. Yao Hsueh Hsueh Bao 1996, 31, 742-745.